File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Management of isolated nodal recurrence after head and neck cancer treatment

TitleManagement of isolated nodal recurrence after head and neck cancer treatment
Authors
KeywordsChemoradiation
Recurrence
Nodal metastasis
Head and neck cancer
Issue Date2013
PublisherStep Communications Ltd. The Journal's web site is located at http://www.touchoncology.com/oncology-journals
Citation
European Oncology & Haematology, 2013, v. 9 n. 2, p. 90-92 How to Cite?
AbstractThe status of the regional cervical lymphatics is one of the most significant prognostic indicators in head and neck cancers. The traditional treatment for cancers with cervical nodal metastasis has been surgical. With the global trend towards organ-preserving therapy, chemoradiation has gained increasing popularity over primary surgical therapies for cancers in the head and neck region. The subsequent management of the neck for those with residual or recurrent nodal metastasis, however, has become one of the most debated topics in the field of head and neck oncology. This review addresses several important controversies, including the optimal assessment of the nodal response to chemoradiation, the potential role and the oncological results of planned and salvage neck dissection after chemoradiation and the type and extent of neck dissection required in order to achieve the optimal balance between tumour control and surgical morbidities. Further clinical trials and ongoing researches will help us to define the best therapeutic option in such circumstances.
Persistent Identifierhttp://hdl.handle.net/10722/199249
ISSN
2015 SCImago Journal Rankings: 0.132

 

DC FieldValueLanguage
dc.contributor.authorChow, VLYen_US
dc.contributor.authorChan, JYWen_US
dc.date.accessioned2014-07-22T01:10:16Z-
dc.date.available2014-07-22T01:10:16Z-
dc.date.issued2013en_US
dc.identifier.citationEuropean Oncology & Haematology, 2013, v. 9 n. 2, p. 90-92en_US
dc.identifier.issn2045-5275-
dc.identifier.urihttp://hdl.handle.net/10722/199249-
dc.description.abstractThe status of the regional cervical lymphatics is one of the most significant prognostic indicators in head and neck cancers. The traditional treatment for cancers with cervical nodal metastasis has been surgical. With the global trend towards organ-preserving therapy, chemoradiation has gained increasing popularity over primary surgical therapies for cancers in the head and neck region. The subsequent management of the neck for those with residual or recurrent nodal metastasis, however, has become one of the most debated topics in the field of head and neck oncology. This review addresses several important controversies, including the optimal assessment of the nodal response to chemoradiation, the potential role and the oncological results of planned and salvage neck dissection after chemoradiation and the type and extent of neck dissection required in order to achieve the optimal balance between tumour control and surgical morbidities. Further clinical trials and ongoing researches will help us to define the best therapeutic option in such circumstances.-
dc.languageengen_US
dc.publisherStep Communications Ltd. The Journal's web site is located at http://www.touchoncology.com/oncology-journals-
dc.relation.ispartofEuropean Oncology & Haematologyen_US
dc.subjectChemoradiation-
dc.subjectRecurrence-
dc.subjectNodal metastasis-
dc.subjectHead and neck cancer-
dc.titleManagement of isolated nodal recurrence after head and neck cancer treatmenten_US
dc.typeArticleen_US
dc.identifier.emailChan, JYW: jywchan1@hku.hken_US
dc.identifier.authorityChan, JYW=rp01314en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.scopuseid_2-s2.0-84896701673-
dc.identifier.hkuros231042en_US
dc.identifier.volume9en_US
dc.identifier.issue2en_US
dc.identifier.spage90en_US
dc.identifier.epage92en_US
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats